We are live on
!
Find out more
NPT
Nixon Peabody Trust Portfolio holdings
AUM
$1.41B
1-Year Est. Return
27.78%
This Fund
S&P 500
This Quarter
Est. Return
-5.86%
1 Year Est. Return
+27.78%
3 Year Est. Return
+85.33%
5 Year Est. Return
+107.3%
10 Year Est. Return
+380.86%
AUM
$291M
AUM Growth
-$39.7M
(-12%)
Cap. Flow
-$17.1M
Cap. Flow
% of AUM
-5.87%
Top 10 Holdings %
Top 10 Hldgs %
35.62%
Holding
92
New
2
Increased
10
Reduced
56
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$812K |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$264K |
| 3 |
Nike
NKE
|
+$236K |
| 4 |
Chevron
CVX
|
+$232K |
| 5 |
Intercontinental Exchange
ICE
|
+$211K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.47M |
| 2 |
Edwards Lifesciences
EW
|
+$1.01M |
| 3 |
NVIDIA
NVDA
|
+$936K |
| 4 |
CVS Health
CVS
|
+$849K |
| 5 |
Microsoft
MSFT
|
+$779K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.8% |
| 2 | Healthcare | 13.34% |
| 3 | Financials | 13.23% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Communication Services | 9.86% |
Similar funds
EWS
KC
CBA
SCM
PTC
QC
BC
EA
Nixon Peabody Trust's Q1 2022 Portfolio in Review
As of Q1 2022, Nixon Peabody Trust held 92 positions worth $291M, down 12% from $330M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Nixon Peabody Trust withdrew a net $17.1M in Q1 2022, closing 11 positions and reducing 56 holdings. Its most notable exit was Edwards Lifesciences, an estimated $1.01M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nixon Peabody Trust opened a new position in Berry Global Group, Inc. worth $241K.
- Nixon Peabody Trust's largest Q1 2022 buy was Berry Global Group, Inc.: 4,522 shares worth $241K.
- Nixon Peabody Trust added most to Bristol-Myers Squibb in Q1 2022, an estimated $812K increase.
- Nixon Peabody Trust's biggest Q1 2022 reduction was Apple, cutting an estimated $1.47M.
- Nixon Peabody Trust fully exited Edwards Lifesciences in Q1 2022, selling an estimated $1.01M.
- Nixon Peabody Trust's ten largest holdings make up 36% of its $291M portfolio in Q1 2022.
- Nixon Peabody Trust opened 2 new positions and closed 11 in Q1 2022.
- Nixon Peabody Trust's portfolio value fell 12% quarter-over-quarter to $291M.
Based on Nixon Peabody Trust's 13F filing for Q1 2022, filed 13 May 2022.